Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
2022 Fee Schedule Calculator, Summary of Medicare Payment Changes Now Available

Jan 12, 2022/News

Get a handle on how CMS changes to the fee schedule, coding, and other issues will affect your practice.

APTA Anxiety Screening Practice Advisory Updated

Jul 5, 2023/News

The USPSTF finalized guidance on screening patients for anxiety. APTA's members-only practice advisory can help you understand your role.

Members-Only Payment Advocacy Resource Collection Grows

Mar 21, 2023/News

The resource center, created by APTA and APTA Private Practice, now offers information on MPPR, the PTA differential, and more.

Video and Photos: APTA 2024 Combined Sections Meeting

Feb 28, 2024/Article

This year's event featured more than 1,200 research posters, 400 sessions from APTA’s 18 specialty sections, 450 exhibitors, the 55th Mary McMillan Lecture, and a specialist recognition ceremony.

Search Now Open for the Next Public Member of the APTA Board

Jul 8, 2024/News

Applications to be the next public member, which cannot be held by a PT or PTA, are due Aug. 15.

Parkinson’s Disease Questionnaire-39 (PDQ-39)

Jan 22, 2013/Test & Measure

This 39-item test is a Parkinson disease-specific health status questionnaire.

Introducing APTA's Fit for Practice Initiative

Oct 6, 2021/Podcast

Learn about APTA Fit for Practice initiative designed to help you recover, evolve, and remain resilient as we move forward into a postpandemic workplace.

Dell Offers Discounts for APTA Members

Aug 19, 2020/News

APTA members can save an extra 5% to 10% off sale prices on a wide range of Dell products.

Making the Connection: A Guide to Social Media, Blogging, and Other Online Tools

Aug 1, 2021/Feature

Many PTs and PTAs are using social media and blogging for everything from networking to education. Here's what they're doing and how you can start.

Pediatric Quality of Life Inventory (PQoL) for Cerebral Palsy (CP)

Jan 21, 2013/Test & Measure

Target population: People with cerebral palsy (CP).